Analyst Research: Regeneron Pharmaceuticals Inc (REGN.OQ)

REGN.OQ on NASDAQ Stock Exchange Global Select Market

271.42USD
12:55pm EDT
Price Change (% chg)

$-6.87 (-2.47%)
Prev Close
$278.29
Open
$277.64
Day's High
$277.64
Day's Low
$271.36
Volume
68,696
Avg. Vol
220,530
52-wk High
$283.00
52-wk Low
$131.50

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - REGENERON PHARMACEUTICALS INCORPORATED (REGN-O) 6:25am EDT Thomson Reuters Stock Report 12 25.00
Trading Report for (REGN). A detailed report, including free correlated market analysis, and updates. 12:58am EDT Stock Traders Daily 5 58.00
ValuEngine Detailed Valuation Report for REGN 31 Jul 2013 ValuEngine, Inc. 11 25.00
Wright Investors Service Comprehensive Report for Regeneron Pharmaceuticals Incorporated 30 Jul 2013 Wright Reports 41 472.00
The Investment Rate - a measure of investment demand. 29 Jul 2013 Stock Traders Daily 43 495.00
Regeneron Pharmaceuticals 27 Jul 2013 S&P Capital IQ – STARS Reports 11 127.00
REGENERON PHARMACEUTICALS INC (REGN) 12-months forecast 26 Jul 2013 Pechala's Reports 1 15.00
TheStreet.com Ratings Stock Report For: REGENERON PHARMACEUT (REGN) 20 Jul 2013 TheStreet.com Ratings 5 10.00
 
Name Age Since Current Position

P. Roy Vagelos

83 1995 Chairman of the Board

Leonard Schleifer

60 1994 President, Chief Executive Officer, Director

Murray Goldberg

68 2000 Chief Financial Officer, Senior Vice President - Finance and Administration, Assistant Secretary

Joseph LaRosa

54 2011 Senior Vice President, General Counsel, Secretary

Daniel Van Plew

40 2008 Senior Vice President, General Manager - Industrial Operations and Product Supply
Search Stocks